{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:52:55Z","timestamp":1791010375244,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"DOI":"10.1007\/s10384-026-01433-1","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:16:34Z","timestamp":1791008194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety outcomes of half-dose fluorescein and indocyanine green angiography: a clinical assessment of adverse events"],"prefix":"10.1007","author":[{"given":"Kouta","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-4148","authenticated-orcid":false,"given":"Koji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusaburo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiteru","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakashizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"1433_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.CIR.24.1.82","volume":"24","author":"HR Novotny","year":"1961","unstructured":"Novotny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 1961;24:82\u20136.","journal-title":"Circulation"},{"key":"1433_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0002-9394(72)90079-7","volume":"73","author":"RW Flower","year":"1972","unstructured":"Flower RW, Hochheimer BF. Clinical infrared absorption angiography of the choroid. Am J Ophthalmol. 1972;73:458\u20139.","journal-title":"Am J Ophthalmol"},{"key":"1433_CR3","first-page":"20","volume":"190","author":"K Hayashi","year":"1985","unstructured":"Hayashi K, de Laey JJ. Indocyanine green angiography of submacular choroidal vessels in the human eye. Ophthalmologica. 1985;190:20\u20139.","journal-title":"Ophthalmologica"},{"key":"1433_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0161-6420(86)33697-2","volume":"93","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, et al. Fluorescein angiography complication survey. Ophthalmology. 1986;93:611\u20137.","journal-title":"Ophthalmology"},{"key":"1433_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0161-6420(94)31303-0","volume":"101","author":"M Hope-Ross","year":"1994","unstructured":"Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, et al. Adverse reactions due to indocyanine green. Ophthalmology. 1994;101:529\u201333.","journal-title":"Ophthalmology"},{"key":"1433_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0161-6420(91)32165-1","volume":"98","author":"KA Kwiterovich","year":"1991","unstructured":"Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, et al. Frequency of adverse systemic reactions after fluorescein angiography: results of a prospective study. Ophthalmology. 1991;98:1139\u201342.","journal-title":"Ophthalmology"},{"key":"1433_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.survophthal.2019.02.004","volume":"64","author":"IS Kornblau","year":"2019","unstructured":"Kornblau IS, El-Annan JF. Adverse reactions to fluorescein angiography: a comprehensive review of the literature. Surv Ophthalmol. 2019;64:679\u201393.","journal-title":"Surv Ophthalmol"},{"key":"1433_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcjo.2016.03.015","volume":"51","author":"K Xu","year":"2016","unstructured":"Xu K, Tzankova V, Li C, Sharma S. Intravenous fluorescein angiography-associated adverse reactions. Can J Ophthalmol. 2016;51:321\u20135.","journal-title":"Can J Ophthalmol"},{"key":"1433_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1590\/S0004-27492007000400011","volume":"70","author":"RP Lira","year":"2007","unstructured":"Lira RP, Oliveira CL, Marques MV, Silva AR, Pessoa CdeC. Adverse reactions of fluorescein angiography: a prospective study. Arq Bras Oftalmol. 2007;70:615\u20138.","journal-title":"Arq Bras Oftalmol"},{"key":"1433_CR10","first-page":"95","volume":"122","author":"Y Oya","year":"2018","unstructured":"Oya Y, Nakamura Y, Ando N. Risk factors for adverse effects and safety measures in fluorescein angiography. Nippon Ganka Gakkai Zasshi. 2018;122:95\u2013102 (in Japanese).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1433_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1442-9071.2006.01136.x","volume":"34","author":"ASL Kwan","year":"2006","unstructured":"Kwan ASL, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006;34:33\u20138.","journal-title":"Clin Exp Ophthalmol"},{"key":"1433_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1136\/bjo.2005.070409","volume":"89","author":"A Bindewald","year":"2005","unstructured":"Bindewald A, Stuhrmann O, Roth F, Schmitz-Valckenberg S, Helb HM, Wegener A, et al. Lower limits of fluorescein and indocyanine green dye for digital cSLO fluorescence angiography. Br J Ophthalmol. 2005;89:1609\u201315.","journal-title":"Br J Ophthalmol"},{"key":"1433_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/2474126420975310","volume":"5","author":"V Patel","year":"2021","unstructured":"Patel V, Syeda S, Zeiter J, Nassiri N, Kim C, Truhan A, et al. Randomized, comparative study of full- and half-dose fluorescein angiography. J Vitreoretin Dis. 2021;5:337\u201344.","journal-title":"J Vitreoretin Dis"},{"key":"1433_CR14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.oret.2024.04.024","volume":"8","author":"A Szigiato","year":"2024","unstructured":"Szigiato A, Sharma S, Singh S, Baynes K, Lowder C, Kaiser PK, et al. Imaging characteristics and clinical utility of half-dose versus full-dose ultrawidefield fundus fluorescein angiography. Ophthalmol Retina. 2024;8:981\u20136.","journal-title":"Ophthalmol Retina"},{"key":"1433_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/IAE.0000000000004420","volume":"45","author":"SH Song","year":"2025","unstructured":"Song SH, Joo K, Woo SJ, Kim MS. Image quality and safety of 300 mg versus 100 mg fluorescein in ultra-widefield fluorescein angiography: a randomized clinical trial. Retina. 2025;45:1168\u201374.","journal-title":"Retina"},{"key":"1433_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"BD McNeil","year":"2015","unstructured":"McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015;519:237\u201341.","journal-title":"Nature"},{"key":"1433_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061223","volume":"18","author":"D Spoerl","year":"2017","unstructured":"Spoerl D, Nigolian H, Czarnetzki C, Harr T. Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed patho-mechanism: IgE-mediated, pharmacological adverse reaction or \u201cinnate hypersensitivity\u201d? Int J Mol Sci. 2017;18:1223.","journal-title":"Int J Mol Sci"},{"key":"1433_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","volume":"4","author":"FER Simons","year":"2011","unstructured":"Simons FER, Ardusso LRF, Bil\u00f2 MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4:13\u201337.","journal-title":"World Allergy Organ J"},{"key":"1433_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.jacc.2008.12.065","volume":"53","author":"DG Benditt","year":"2009","unstructured":"Benditt DG, Nguyen JT. Syncope: therapeutic approaches. J Am Coll Cardiol. 2009;53:1741\u201351.","journal-title":"J Am Coll Cardiol"},{"key":"1433_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00471","volume":"5","author":"RMFL da Silva","year":"2014","unstructured":"da Silva RMFL. Syncope: epidemiology, etiology, and prognosis. Front Physiol. 2014;5:471.","journal-title":"Front Physiol"},{"key":"1433_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/bjd.17268","volume":"180","author":"SM Pilkington","year":"2019","unstructured":"Pilkington SM, Barron MJ, Watson REB, Griffiths CEM, Bulfone-Paus S. Aged human skin accumulates mast cells with altered functionality that localize to macrophages and vasoactive intestinal peptide-positive nerve fibres. Br J Dermatol. 2019;180:849\u201358.","journal-title":"Br J Dermatol"},{"key":"1433_CR22","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s003300000729","volume":"11","author":"SK Morcos","year":"2001","unstructured":"Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol. 2001;11:1267\u201375.","journal-title":"Eur Radiol"},{"key":"1433_CR23","first-page":"533","volume":"8","author":"GS Greene","year":"1976","unstructured":"Greene GS, Bell LW, Hitching RA, Spaeth GL. Adverse reaction to intravenous fluorescein: evidence for sex difference. Ann Ophthalmol. 1976;8:533\u20136.","journal-title":"Ann Ophthalmol"},{"key":"1433_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3129\/i08-122","volume":"43","author":"KA Moosbrugger","year":"2008","unstructured":"Moosbrugger KA, Sheidow TG. Evaluation of the side effects and image quality during fluorescein angiography comparing 2 mL and 5 mL sodium fluorescein. Can J Ophthalmol. 2008;43:571\u20135.","journal-title":"Can J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01433-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01433-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:16:36Z","timestamp":1791008196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01433-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":24,"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01433-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K. Kawasaki, None; K. Tanaka, None; R. Mori, None; H. Goto, None; T. Kobayashi, None; A. Nakai, None; M. Kono, None; Y. Wakatsuki, None; A. Kawamura, None; H. Nakashizuka, None.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}